HealthPartners Frauenshuh Cancer center

Saint Louis Park, Minnesota 55426

7 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Advanced or Metastatic Solid Tumors, Bladder Cancer, Brain Neoplasms, Breast Cancer, Breast Cancer, Metastatic, Cervical Cancer, Differentiated Thyroid Cancer, Ductal Carcinoma in Situ, EGFR Mutation-Related Tumors, Endometrial Cancer, Esophageal Cancer

Studies at this site

• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — Recruiting now
• DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment — Recruiting now
• XTX301 in Patients With Advanced Solid Tumors — Recruiting now
• ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer — Withdrawn before enrolling
• A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer — Running, not enrolling